Offer - Urjas Oil for just ₹ 1 X
Oflokay OZ Syrup is a commercial drug that is prescribed in the form of Syrup. Oflokay OZ Syrup also has some secondary and off-label uses. These are listed below.
The right dosage of Oflokay OZ Syrup depends on the age, gender, and medical history of the patient. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Detailed information has been provided in the dosage section.
The most common side effects of Oflokay OZ Syrup are Abdominal Pain, Nausea or vomiting, Skin Rash. Besides the aforementioned side effects, there are other adverse effects of Oflokay OZ Syrup as well, which are listed below. These side effects of Oflokay OZ Syrup are usually temporary and subside with the completion of treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Furthermore, you should know that effect of Oflokay OZ Syrup is Moderate for pregnant women and Moderate for women who are breastfeeding. Further, the section on Oflokay OZ Syrup related warnings talks about Oflokay OZ Syrup's effects on the liver, heart and kidney.
Individuals suffering from medical conditions like Heart Disease, Stomach Disease must refrain from the use of Oflokay OZ Syrup since this can cause severe adverse effects. Other conditions have been mentioned below in the Oflokay OZ Syrup contraindications section.
Besides this, Oflokay OZ Syrup may also have severe interaction with some medicines. A complete list of these interactions is given below.
Along with the above-mentioned precautions, remember that taking Oflokay OZ Syrup is considered safe while driving, and is addictive.
Oflokay OZ Syrup is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
2 - 12 years (Child) |
|
Infant (1 month to 2 years) |
|
Is the use of Oflokay OZ Syrup safe for pregnant women?
Oflokay Oz can have harmful effects in pregnant women. If you experience any discomfort after using Oflokay Oz, then discontinue the use and take your doctor's advice.
Is the use of Oflokay OZ Syrup safe during breastfeeding?
Oflokay Oz may lead to some side effects in breastfeeding women. If you witness any unusal symptoms after taking Oflokay Oz, discontinue its use and call your doctor right away. Follow your doctor's advice regarding the use of Oflokay Oz.
What is the effect of Oflokay OZ Syrup on the Kidneys?
There are no side effects of Oflokay Oz on the kidneys.
What is the effect of Oflokay OZ Syrup on the Liver?
There may be an adverse effect on the liver after taking Oflokay Oz. If you observe any side effects on your body then stop taking this drug. Take this medicine again only if your doctor advises you to do so.
What is the effect of Oflokay OZ Syrup on the Heart?
You may experience side effects on your heart after taking Oflokay Oz. If this happens, then discontinue its use. Consult your medical practitioner, and do as he/she suggests.
Oflokay OZ Syrup should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Oflokay OZ Syrup unless your doctor advises you to do so -
Is this Oflokay OZ Syrup habit forming or addictive?
No, you will not get addicted to Oflokay OZ Syrup.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can operate a vehicle or heavy machinery after taking Oflokay OZ Syrup since it does not cause drowsiness.
Is it safe?
Yes, Oflokay OZ Syrup is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
No, Oflokay OZ Syrup cannot treat any kind of mental disorder.
Interaction between Food and Oflokay OZ Syrup
Taking Oflokay OZ Syrup with food does not cause any problems.
Interaction between Alcohol and Oflokay OZ Syrup
Consult your doctor before consuming alcohol while taking Oflokay OZ Syrup as it can have severe side effects.
Take Oflokay Oz as directed by your doctor. Do not take this medicine longer than prescribed.
Yes, you can take Oflokay Oz for UTI infection. It is the first-line drug for treating UTI infection. It is active against the bacteria which causes UTI infection. However, you must follow the entire course of this medicine and do not discontinue medication without consulting your doctor.
Oflokay Oz can be taken with doxycycline. No drug-drug interactions are reported between them. Doxycyclin also does not affect the absorption of this drug. However, it doesn't mean that no interaction could exist. Please consult your doctor, if you feel any complication after consuming these two medicines at the same time.
Yes, long-term use of Oflokay Oz can increase the risk of tendonitis and tendon rupture in some people. However, the exact mechanism of tendon rupture is not known. If you suffer from tendon rupture or any kind of muscular pain after consuming this drug, please consult your doctor immediately.
Oflokay Oz is not recommended as the first-line of drug for treating sinus infection. However, if there are no other alternatives available then you can take it, after doctor's advice.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1400
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 713
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Floxin® (ofloxacin)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ocuflox® (ofloxacin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 839